Protagenic Therapeutics, Inc. (PTIX)
1.026
-0.03
(-3.22%)
USD |
OTCM |
Sep 08, 16:00
Protagenic Therapeutics Shareholders Equity (Quarterly) : 1.723M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.723M |
| March 31, 2026 | 2.619M |
| December 31, 2025 | -2.393M |
| September 30, 2025 | -4.701M |
| June 30, 2025 | -3.974M |
| March 31, 2025 | -0.0883M |
| December 31, 2024 | 1.013M |
| September 30, 2024 | 0.719M |
| June 30, 2024 | 0.7925M |
| March 31, 2024 | 2.132M |
| December 31, 2023 | 3.668M |
| September 30, 2023 | 4.152M |
| June 30, 2023 | 5.414M |
| March 31, 2023 | 6.414M |
| December 31, 2022 | 6.918M |
| September 30, 2022 | 7.382M |
| June 30, 2022 | 8.258M |
| March 31, 2022 | 8.720M |
| December 31, 2021 | 9.942M |
| September 30, 2021 | 10.37M |
| June 30, 2021 | 10.80M |
| March 31, 2021 | -1.983M |
| December 31, 2020 | -1.150M |
| September 30, 2020 | -1.021M |
| June 30, 2020 | -0.7461M |
| Date | Value |
|---|---|
| March 31, 2020 | -0.5859M |
| December 31, 2019 | -0.6344M |
| September 30, 2019 | -0.3637M |
| June 30, 2019 | -0.3795M |
| March 31, 2019 | -0.3618M |
| December 31, 2018 | -0.2109M |
| September 30, 2018 | 0.323M |
| June 30, 2018 | 0.5599M |
| March 31, 2018 | 0.9649M |
| December 31, 2017 | 1.219M |
| September 30, 2017 | 1.683M |
| June 30, 2017 | 1.877M |
| March 31, 2017 | 2.177M |
| December 31, 2016 | 2.477M |
| September 30, 2016 | 2.939M |
| June 30, 2016 | 3.186M |
| March 31, 2016 | 3.016M |
| June 30, 2015 | -0.497M |
| March 31, 2015 | -0.385M |
| December 31, 2014 | -0.266M |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 | |
| December 31, 2013 | |
| September 30, 2013 |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 465.53M |
| Oncolytics Biotech, Inc. | -6.167M |
| Sangamo Therapeutics, Inc. | -18.96M |
| Sarepta Therapeutics, Inc. | 1.528B |
| Anixa Biosciences, Inc. | 14.48M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 2.796M |
| Total Liabilities (Quarterly) | 1.073M |
| Current Ratio | 0.6619 |